Table 2

TP53 frequency and association with invasive cervical cancer in Peruvian women

GenotypeCases n (%)Controls n (%)OR [95% CI]aOR [95% CI]b
All women119 (100)127 (100)
Pro/Pro14 (11.8)16 (12.6)1.0 (ref. cat.)1.0 (ref. cat.)
Arg/Pro45 (37.8)45 (35.4)1.1 [0.5–2.6]3.5 [0.9–14]
Arg/Arg60 (50.4)66 (52.0)1.0 [0.5–2.3]2.2 [0.6–7.6]
HPV-positive women only112 (100)17 (100)
Pro/Pro13 (11.6)4 (23.5)1.0 (ref. cat.)
Arg/Pro41 (36.6)5 (29.4)2.6 [0.6–11]
Arg/Arg58 (51.8)8 (47.1)2.2 [0.6–8.6]
  • a OR adjusted for age.

  • b OR adjusted for age and HPV.